Telestroke Consultation in the Emergency Medical Services Unit: A Novel Approach to Improve Thrombolysis Times

J Stroke Cerebrovasc Dis. 2021 May;30(5):105710. doi: 10.1016/j.jstrokecerebrovasdis.2021.105710. Epub 2021 Mar 6.

Abstract

Background: Faster treatment times are associated with improved outcomes in patients with acute ischemic stroke. In this prospective pilot study, we assess the feasibility of initiating telestroke consultation in emergency medical services unit (TEMS).

Methods: Patients with stroke symptoms were evaluated via TEMS using a video-call with a stroke provider. After TEMS evaluation, patients were transferred to the nearest stroke center (NSC) or thrombectomy capable center (TCS) depending on stroke severity and symptom onset time. We compared time metrics between patients evaluated via TEMS to those via standard telestroke (STS) consultation.

Results: 49 patients were evaluated via TEMS between May 2017 and March 2020. Median age was 66, 24 (49%) were females, 15 (30.6%) received intravenous alteplase (tPA) after arrival to a local hospital, and 3 (6.1%) underwent mechanical thrombectomy (MT) after bypassing the NSC. Compared to 52 tPA patients treated through STS consultation, TEMS patients had shorter door to needle (DTN) time (21 vs. 38 min, p < 0.001). In addition, patients who received MT after bypassing the NSC had shorter onset to groin time compared to those transferred from NSC (216 vs. 293 min, P = 0.04).

Conclusion: Prehospital stroke triaging using TEMS is feasible, and could result in shorter DTN and onset to groin times.

Keywords: EMS; Endovascular therapy; Prehospital triage; Telestroke; thrombolysis.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Clinical Decision-Making
  • Emergency Medical Services*
  • Endovascular Procedures* / adverse effects
  • Feasibility Studies
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Pilot Projects
  • Prospective Studies
  • Remote Consultation*
  • Stroke / diagnosis
  • Stroke / physiopathology
  • Stroke / therapy*
  • Thrombectomy* / adverse effects
  • Thrombolytic Therapy* / adverse effects
  • Time Factors
  • Time-to-Treatment*
  • Tissue Plasminogen Activator / administration & dosage*
  • Tissue Plasminogen Activator / adverse effects
  • Transportation of Patients*
  • Treatment Outcome
  • Triage*
  • Videoconferencing

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator